Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants

NCT05599802 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: SARS-CoV-2 variant mRNA vaccine low dose
BIOLOGICAL: SARS-CoV-2 variant mRNA vaccine high dose

Sponsor

AIM Vaccine Co., Ltd.

Collaborators

[object Object]
[object Object]